{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:41:51Z","timestamp":1761986511588,"version":"3.37.3"},"reference-count":51,"publisher":"Wiley","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Allergy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13601-017-0188-1","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T13:01:29Z","timestamp":1515762089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis and erythema multiforme drug-related hospitalisations in a national administrative database"],"prefix":"10.1002","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1277-3401","authenticated-orcid":false,"given":"Bernardo","family":"Sousa-Pinto","sequence":"first","affiliation":[]},{"given":"Lu\u00eds","family":"Ara\u00fajo","sequence":"additional","affiliation":[]},{"given":"Alberto","family":"Freitas","sequence":"additional","affiliation":[]},{"given":"Osvaldo","family":"Correia","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Delgado","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2018,1,22]]},"reference":[{"issue":"262\u201371","key":"188_CR1","first-page":"e2","volume":"136","author":"LM Wheatley","year":"2015","unstructured":"Wheatley LM, Plaut M, Schwaninger JM, Banerji A, Castells M, Finkelman FD, et al. Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy. J Allergy Clin Immunol. 2015;136(262\u201371):e2.","journal-title":"J Allergy Clin Immunol"},{"key":"188_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jaip.2013.11.005","volume":"2","author":"R Pavlos","year":"2014","unstructured":"Pavlos R, Mallal S, Ostrov D, Pompeu Y, Phillips E. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy. J Allergy Clin Immunol Pract. 2014;2:21\u201333.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"188_CR3","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.mcna.2015.06.003","volume":"99","author":"L Swanson","year":"2015","unstructured":"Swanson L, Colven RM. Approach to the patient with a suspected cutaneous adverse drug reaction. Med Clin N Am. 2015;99:1337\u201348.","journal-title":"Med Clin N Am"},{"key":"188_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1750-1172-7-72","volume":"7","author":"S Bouvresse","year":"2012","unstructured":"Bouvresse S, Valeyrie-Allanore L, Ortonne N, Konstantinou MP, Kardaun SH, Bagot M, et al. Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist? Orphanet J Rare Dis. 2012;7:72.","journal-title":"Orphanet J Rare Dis"},{"key":"188_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1503\/cmaj.090137","volume":"181","author":"MA Leclair","year":"2009","unstructured":"Leclair MA, Maynard B, St-Pierre C. Acute generalized exanthematous pustulosis with severe organ dysfunction. CMAJ. 2009;181:393\u20136.","journal-title":"CMAJ"},{"key":"188_CR6","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/cid\/ciu126","volume":"58","author":"YF Lin","year":"2014","unstructured":"Lin YF, Yang CH, Sindy H, Lin JY, Rosaline Hui CY, Tsai YC, et al. Severe cutaneous adverse reactions related to systemic antibiotics. Clin Infect Dis. 2014;58:1377\u201385.","journal-title":"Clin Infect Dis"},{"key":"188_CR7","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.autrev.2008.06.004","volume":"7","author":"AT Borchers","year":"2008","unstructured":"Borchers AT, Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Autoimmun Rev. 2008;7:598\u2013605.","journal-title":"Autoimmun Rev"},{"key":"188_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1172-5-39","volume":"5","author":"T Harr","year":"2010","unstructured":"Harr T, French LE. Toxic epidermal necrolysis and Stevens\u2013Johnson syndrome. Orphanet J Rare Dis. 2010;5:39.","journal-title":"Orphanet J Rare Dis"},{"key":"188_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2165\/00128071-200304080-00006","volume":"4","author":"N Bachot","year":"2003","unstructured":"Bachot N, Roujeau JC. Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol. 2003;4:561\u201372.","journal-title":"Am J Clin Dermatol"},{"key":"188_CR10","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/j.1346-8138.1997.tb02524.x","volume":"24","author":"JC Roujeau","year":"1997","unstructured":"Roujeau JC. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme. J Dermatol. 1997;24:726\u20139.","journal-title":"J Dermatol"},{"key":"188_CR11","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","volume":"138","author":"A Auquier-Dunant","year":"2002","unstructured":"Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC, et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens\u2013Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002;138:1019\u201324.","journal-title":"Arch Dermatol"},{"key":"188_CR12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1177\/039463200702000313","volume":"20","author":"AV Marzano","year":"2007","unstructured":"Marzano AV, Frezzolini A, Caproni M, Parodi A, Fanoni D, Quaglino P, et al. Immunohistochemical expression of apoptotic markers in drug-inducederythema multiforme, Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Int J Immunopathol Pharmacol. 2007;20:557\u201366.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"188_CR13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1684\/ejd.2011.1510","volume":"21","author":"R Watanabe","year":"2011","unstructured":"Watanabe R, Watanabe H, Sotozono C, Kokaze A, Iijima M. Critical factors differentiating erythema multiforme majus from Stevens\u2013Johnson syndrome (SJS)\/toxic epidermal necrolysis (TEN). Eur J Dermatol. 2011;21:889\u201394.","journal-title":"Eur J Dermatol"},{"key":"188_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/pds.3937","volume":"25","author":"J Diphoorn","year":"2016","unstructured":"Diphoorn J, Cazzaniga S, Gamba C, Schroeder J, Citterio A, Rivolta AL, et al. Incidence, causative factors and mortality rates of Stevens\u2013Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry. Pharmacoepidemiol Drug Saf. 2016;25:196\u2013203.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"188_CR15","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","volume":"333","author":"JC Roujeau","year":"1995","unstructured":"Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens\u2013Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333:1600\u20137.","journal-title":"N Engl J Med"},{"key":"188_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/bcp.12474","volume":"80","author":"EW Chan","year":"2015","unstructured":"Chan EW, Liu KQ, Chui CS, Sing CW, Wong LY, Wong IC. Adverse drug reactions\u2014examples of detection of rare events using databases. Br J Clin Pharmacol. 2015;80:855\u201361.","journal-title":"Br J Clin Pharmacol"},{"key":"188_CR17","unstructured":"Mateus C. Portugal. Results of 25\u00a0years of experience with DRGs. In: Busse R, World Health Organization, Regional Office for Europe, EuroDRG (Project), , editors. Diagnosis-related groups in Europe: moving towards transparency, efficiency and quality in hospitals. Berkshire: McGraw-Hill Open University Press; 2011."},{"key":"188_CR18","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/pds.3778","volume":"24","author":"RL Davis","year":"2015","unstructured":"Davis RL, Gallagher MA, Asgari MM, Eide MJ, Margolis DJ, Macy E, et al. Identification of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in electronic health record databases. Pharmacoepidemiol Drug Saf. 2015;24:684\u201392.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"188_CR19","unstructured":"Instituto Nacional de Estat\u00edstica (Portuguese Institute of Statistics). https:\/\/www.ine.pt\/ . Accessed 26 Mar 2016."},{"key":"188_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000448217","volume":"170","author":"B Sousa-Pinto","year":"2016","unstructured":"Sousa-Pinto B, Correia C, Gomes L, Gil-Mata S, Ara\u00fajo L, Correia O, et al. HLA and delayed drug-induced hypersensitivity. Int Arch Allergy Immunol. 2016;170:163\u201379.","journal-title":"Int Arch Allergy Immunol"},{"key":"188_CR21","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s40264-013-0084-0","volume":"36","author":"SN Ramasamy","year":"2013","unstructured":"Ramasamy SN, Korb-Wells CS, Kannangara DR, Smith MW, Wang N, Roberts DM, et al. Allopurinol hypersensitivity: a systematic review of all published cases, 1950\u20132012. Drug Saf. 2013;36:953\u201380.","journal-title":"Drug Saf"},{"key":"188_CR22","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/archderm.1993.01680290135026","volume":"129","author":"B Rzany","year":"1993","unstructured":"Rzany B, Mockenhaupt M, Stocker U, Hamouda O, Schopf E. Incidence of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany. Arch Dermatol. 1993;129:1059.","journal-title":"Arch Dermatol"},{"issue":"4_MeetingAbstra","key":"188_CR23","doi-asserted-by":"publisher","first-page":"124A","DOI":"10.1378\/chest.1118558","volume":"140","author":"W Gao","year":"2011","unstructured":"Gao W, Tiwary A, McGann A, Rajmane R. Chronic infection with hepatitis C as a risk factor for toxic epidermal necrolysis in a cirrhotic patient with streptococcus pneumoniae bacteremia. Chest. 2011;140(4_MeetingAbstracts):124A.","journal-title":"Chest"},{"key":"188_CR24","unstructured":"INFARMED\u2014Autoridade Nacional do Medicamento e Produtos de Sa\u00fade I.P. Estat\u00edstica do Medicamento 2010 (Medicines Statistic 2010). http:\/\/www.infarmed.pt\/portal\/page\/portal\/INFARMED\/MONITORIZACAO_DO_MERCADO\/OBSERVATORIO\/ESTATISTICA_DO_MEDICAMENTO\/ESTATISTICA_DO_MEDICAMENTO_ANTERIORES\/EstMed-2010_0.pdf . Accessed 26 Mar 2016."},{"key":"188_CR25","unstructured":"INFARMED\u2014Autoridade Nacional do Medicamento e Produtos de Sa\u00fade I.P. Estat\u00edstica do Medicamento 2011 (Medicines Statistic 2011). http:\/\/www.infarmed.pt\/portal\/page\/portal\/INFARMED\/PUBLICACOES\/TEMATICOS\/ESTATISTICA_MEDICAMENTO\/EstMed-2011.pdf . Accessed 26 Mar 2016."},{"key":"188_CR26","unstructured":"INFARMED\u2014Autoridade Nacional do Medicamento e Produtos de Sa\u00fade I.P. Estat\u00edstica do Medicamento 2012 (Medicines Statistic 2012). http:\/\/www.infarmed.pt\/portal\/page\/portal\/INFARMED\/MONITORIZACAO_DO_MERCADO\/OBSERVATORIO\/ESTATISTICA_DO_MEDICAMENTO\/ESTATISTICA_DO_MEDICAMENTO_ANTERIORES\/EstMed-2012.pdf . Accessed 26 Mar 2016."},{"key":"188_CR27","unstructured":"INFARMED\u2014Autoridade Nacional do Medicamento e Produtos de Sa\u00fade I.P. Estat\u00edstica do Medicamento 2013 (Medicines Statistic 2013). http:\/\/www.infarmed.pt\/portal\/page\/portal\/INFARMED\/MONITORIZACAO_DO_MERCADO\/OBSERVATORIO\/ESTATISTICA_DO_MEDICAMENTO\/ESTATISTICA_DO_MEDICAMENTO_ANTERIORES\/Estat_Medic_2013_0.pdf . Accessed 26 Mar 2016."},{"key":"188_CR28","unstructured":"INFARMED\u2014Autoridade Nacional do Medicamento e Produtos de Sa\u00fade I.P. Estat\u00edstica do Medicamento e Produtos de Sa\u00fade 2014 (Medicine and Healthcare Products Statistics 2014). http:\/\/www.infarmed.pt\/portal\/page\/portal\/INFARMED\/MONITORIZACAO_DO_MERCADO\/OBSERVATORIO\/ESTATISTICA_DO_MEDICAMENTO\/Estat_Medic_2014_final_13%2011%202015.pdf . Accessed 26 Mar 2016."},{"key":"188_CR29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cden.2013.07.001","volume":"57","author":"F Samim","year":"2013","unstructured":"Samim F, Auluck A, Zed C, Williams PM. Erythema multiforme: a review of epidemiology, pathogenesis, clinical features, and treatment. Dent Clin N Am. 2013;57:583\u201396.","journal-title":"Dent Clin N Am"},{"key":"188_CR30","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/bjd.14841","volume":"175","author":"JC Roujeau","year":"2016","unstructured":"Roujeau JC. Re-evaluation of \u2018drug-induced\u2019 erythema multiforme in medical literature. Br J Dermatol. 2016;175:650\u20131.","journal-title":"Br J Dermatol"},{"key":"188_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00015550310002611","volume":"83","author":"A Rotunda","year":"2003","unstructured":"Rotunda A, Hirsch RJ, Scheinfeld N, Weinberg JM. Severe cutaneous reactions associated with the use of human immunodeficiency virus medications. Acta Derm Venereol. 2003;83:1\u20139.","journal-title":"Acta Derm Venereol"},{"key":"188_CR32","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.jaad.2013.12.025","volume":"70","author":"C Yang","year":"2014","unstructured":"Yang C, Mosam A, Mankahla A, Dlova N, Saavedra A. HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed CD4(+) T cells. J Am Acad Dermatol. 2014;70:1096\u2013102.","journal-title":"J Am Acad Dermatol"},{"key":"188_CR33","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/S0140-6736(94)90597-5","volume":"344","author":"O Correia","year":"1994","unstructured":"Correia O, Delgado L, Santos C, Miranda AM. HIV-1 in blister fluid of a patient with toxic epidermal necrolysis and AIDS. Lancet. 1994;344:1432\u20133.","journal-title":"Lancet"},{"key":"188_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","volume":"58","author":"J Schneck","year":"2008","unstructured":"Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M. Effects of treatments on the mortality of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol. 2008;58:33\u201340.","journal-title":"J Am Acad Dermatol"},{"key":"188_CR35","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1001\/jama.2014.839","volume":"311","author":"Y Finkelstein","year":"2014","unstructured":"Finkelstein Y, Macdonald EM, Li P, Hutson JR, Juurlink DN. Recurrence and mortality following severe cutaneous adverse reactions. JAMA. 2014;311:2231\u20132.","journal-title":"JAMA"},{"key":"188_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/BCR.0b013e31820aafbc","volume":"32","author":"P Sekula","year":"2011","unstructured":"Sekula P, Liss Y, Davidovici B, Dunant A, Roujeau JC, Kardaun S, et al. Evaluation of SCORTEN on a cohort of patients with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study. J Burn Care Res. 2011;32:237\u201345.","journal-title":"J Burn Care Res"},{"key":"188_CR37","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/ACI.0000000000000181","volume":"15","author":"YK Heng","year":"2015","unstructured":"Heng YK, Lim YL. Cutaneous adverse drug reactions in the elderly. Curr Opin Allergy Clin Immunol. 2015;15:300\u20137.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"188_CR38","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/hep.28270","volume":"63","author":"H Devarbhavi","year":"2016","unstructured":"Devarbhavi H, Raj S, Aradya VH, Rangegowda VT, Veeranna GP, Singh R, et al. Drug-induced liver injury Associated with Stevens-Johnson syndrome\/toxic epidermal necrolysis: patient characteristics, causes and outcome in 36 Cases. Hepatology. 2016;63:993\u20139.","journal-title":"Hepatology."},{"key":"188_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1053\/j.seminoncol.2005.11.004","volume":"33","author":"AS Payne","year":"2006","unstructured":"Payne AS, James WD, Weiss RB. Dermatologic toxicity of chemotherapeutic agents. Semin Oncol. 2006;33:86\u201397.","journal-title":"Semin Oncol"},{"key":"188_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.det.2007.08.006","volume":"26","author":"RE Sanborn","year":"2008","unstructured":"Sanborn RE, Sauer DA. Cutaneous reactions to chemotherapy: commonly seen, less described, little understood. Dermatol Clin. 2008;26:103\u201319.","journal-title":"Dermatol Clin"},{"key":"188_CR41","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/COC.0b013e31825d5835","volume":"37","author":"TZ Vern-Gross","year":"2014","unstructured":"Vern-Gross TZ, Kowal-Vern A. Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis syndrome in patients undergoing radiation therapy: a literature review. Am J Clin Oncol. 2014;37:506\u201313.","journal-title":"Am J Clin Oncol"},{"key":"188_CR42","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/pds.3468","volume":"22","author":"A Miguel","year":"2013","unstructured":"Miguel A, Bernardo M, Freitas A, Lopes F, Azevedo L, Pereira AC. Detection of adverse drug reactions using hospital databases\u2014a nationwide study in Portugal. Pharmacoepidemiol Drug Saf. 2013;22:907\u201313.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"188_CR43","doi-asserted-by":"publisher","first-page":"666","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00048","volume":"127","author":"LI Iezzoni","year":"1997","unstructured":"Iezzoni LI. Assessing quality using administrative data. Ann Intern Med. 1997;127:666\u201374.","journal-title":"Ann Intern Med"},{"issue":"811\u20137","key":"188_CR44","first-page":"e4","volume":"76","author":"DY Hsu","year":"2017","unstructured":"Hsu DY, Brieva J, Silverberg NB, Paller AS, Silverberg JI. Pediatric Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in the United States. J Am Acad Dermatol. 2017;76(811\u20137):e4.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"188_CR45","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/pds.2331","volume":"21","author":"G Schneider","year":"2012","unstructured":"Schneider G, Kachroo S, Jones N, Crean S, Rotella P, Avetisyan R, et al. A systematic review of validated methods for identifying erythema multiforme major\/minor\/not otherwise specified, Stevens\u2013Johnson Syndrome, or toxic epidermal necrolysis using administrative and claims data. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 1):236\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"188_CR46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jaip.2015.07.013","volume":"4","author":"RR Saff","year":"2016","unstructured":"Saff RR, Camargo CA, Jr, Clark S, Rudders SA, Long AA, Banerji A. Utility of ICD-9-CM codes for identification of allergic drug reactions. J Allergy Clin Immunol Pract. 2016;4:114\u20139.","journal-title":"J Allergy Clin Immunol Pract."},{"key":"188_CR47","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/1346-8138.13810","volume":"44","author":"H Nomura","year":"2017","unstructured":"Nomura H, Takahashi H, Suzuki S, Kurihara Y, Chubachi S, Kawada I, et al. Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapy. J Dermatol. 2017;44:818\u201321.","journal-title":"J Dermatol."},{"key":"188_CR48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1684\/ejd.2016.2912","volume":"27","author":"R Laurinaviciene","year":"2017","unstructured":"Laurinaviciene R, Sandholdt LH, Bygum A. Drug-induced cutaneous lupus erythematosus: 88 new cases. Eur J Dermatol. 2017;27:28\u201333.","journal-title":"Eur J Dermatol"},{"key":"188_CR49","unstructured":"World Health Organization. ICD-10 Version 2016. http:\/\/apps.who.int\/classifications\/icd10\/browse\/2016\/en . Accessed 29 Aug 2016."},{"key":"188_CR50","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jaip.2016.01.015","volume":"4","author":"LK Tanno","year":"2016","unstructured":"Tanno LK, Calderon MA, Li J, Casale T, Demoly P, Joint Allergy Academies. Updating allergy and\/or hypersensitivity diagnostic procedures in the WHO ICD-11 revision. J Allergy Clin Immunol Pract. 2016;4:650\u20137.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"188_CR51","unstructured":"World Health Organization. ICD-11 Beta Draft (Last uptadte 2017 November 25). https:\/\/icd.who.int\/dev11\/l-m\/en . Acessed 26 Nov 2017."}],"container-title":["Clinical and Translational Allergy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13601-017-0188-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T22:43:27Z","timestamp":1609454607000},"score":1,"resource":{"primary":{"URL":"https:\/\/ctajournal.biomedcentral.com\/articles\/10.1186\/s13601-017-0188-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,22]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["188"],"URL":"https:\/\/doi.org\/10.1186\/s13601-017-0188-1","relation":{},"ISSN":["2045-7022"],"issn-type":[{"type":"electronic","value":"2045-7022"}],"subject":[],"published":{"date-parts":[[2018,1,22]]},"assertion":[{"value":"24 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2"}}